SHCR vs. PIII, MYPS, DCGO, TALK, LTCH, INNV, WGS, PNTG, PSTX, and TLSI
Should you be buying Sharecare stock or one of its competitors? The main competitors of Sharecare include P3 Health Partners (PIII), PLAYSTUDIOS (MYPS), DocGo (DCGO), Talkspace (TALK), Latch (LTCH), InnovAge (INNV), GeneDx (WGS), The Pennant Group (PNTG), Poseida Therapeutics (PSTX), and TriSalus Life Sciences (TLSI).
P3 Health Partners (NASDAQ:PIII) and Sharecare (NASDAQ:SHCR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, institutional ownership, earnings and analyst recommendations.
P3 Health Partners has higher revenue and earnings than Sharecare. Sharecare is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.
7.8% of P3 Health Partners shares are held by institutional investors. Comparatively, 35.1% of Sharecare shares are held by institutional investors. 17.1% of P3 Health Partners shares are held by insiders. Comparatively, 29.3% of Sharecare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Sharecare had 12 more articles in the media than P3 Health Partners. MarketBeat recorded 16 mentions for Sharecare and 4 mentions for P3 Health Partners. Sharecare's average media sentiment score of 0.97 beat P3 Health Partners' score of -0.03 indicating that P3 Health Partners is being referred to more favorably in the media.
P3 Health Partners presently has a consensus target price of $4.75, indicating a potential upside of 691.53%. Sharecare has a consensus target price of $1.00, indicating a potential upside of 27.50%. Given Sharecare's stronger consensus rating and higher possible upside, equities analysts plainly believe P3 Health Partners is more favorable than Sharecare.
P3 Health Partners has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Comparatively, Sharecare has a beta of 0.26, indicating that its share price is 74% less volatile than the S&P 500.
Sharecare received 2 more outperform votes than P3 Health Partners when rated by MarketBeat users. Likewise, 35.29% of users gave Sharecare an outperform vote while only 28.57% of users gave P3 Health Partners an outperform vote.
P3 Health Partners has a net margin of -4.97% compared to P3 Health Partners' net margin of -30.71%. P3 Health Partners' return on equity of -19.78% beat Sharecare's return on equity.
Summary
P3 Health Partners beats Sharecare on 10 of the 18 factors compared between the two stocks.
Get Sharecare News Delivered to You Automatically
Sign up to receive the latest news and ratings for SHCR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SHCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sharecare Competitors List
Related Companies and Tools
